9th January — 17:00 UTC (check local time) 

Brian Pierchala
Sherry L. Sonneborn Professor and Executive Associate Director, Stark Neurosciences Research Institute, IUSM. Speaking from Indianapolis, IN, USA.

Development of peripheral sensory and autonomic neurons

While much is known about the cell fate specification and diversity of sensory neurons of the dorsal root ganglion, our understanding of other PNS populations is limited. I will present data on the development of sympathetic and chemosensory neurons and their circuit architecture.

13th February — 16:00 UTC (check local time) 

Maria Anna Papadopoulou
Postdoctoral Researcher at the Institute of Molecular Biology and Biotechnology. Speaking from Crete, Greece.

p75NTR in Adult Neurogenesis, under Alzheimer's Disease

Investigating the role of the p75NTR in adult hippocampal neurogenesis, using mouse and human neural stem cells, will offer insights into potential therapeutic avenues for addressing Alzheimer's Disease-related neurogenesis deficits.

13th March — 16:00 UTC (check local time) 

Lino Tessarollo
Director Mouse Cancer Genetics Program and Head Neural Development Section, Center for Cancer Research, National Cancer Institute. Speaking from Bethesda, MD, USA.

TrkB.T1: 35 years from its discovery, the quest for its function continues.

The TrkB gene, encodes a tyrosine kinase receptor and a receptor lacking the tyrosine kinase domain, TrkB.T1. TrkB.T1, is the most widely expressed isoform in the adult. However, how it functions is still unknown. I will describe its distribution, known in vivo functions, and possible roles in regulating BDNF signaling.

10th April — 16:00 UTC (check local time) 

Glen Wickersham García
Graduate Research Fellow at the Institute of Biology University of Puerto Rico Rio Piedras. Speaking from San Juan, Puerto Rico.

Characterization of neuronal growth factors in the genome of Holothuria glaberrima

The sea cucumber, Holothuria glaberrima, is a promising model to study enteric nervous system regeneration. Growth Factors have been implicated to have direct roles in these processes. Three neurotrophin homologs and three tropomyosin receptor kinases have been characterized in its genome.

8th May — 16:00 UTC (check local time) 

David Villarroel Campos
Postdoctoral researcher at the Sleigh Lab, UCL Queen Square Institute of Neurology, University College London. Speaking from London, United Kingdom.

Boosting GDNF as a therapy for Charcot-Marie-Tooth disease

We are developing an AAV strategy to increase GDNF expression in skeletal muscle. This could act as a protective intervention for inherited neuropathies, and we are testing it in models of Charcot-Marie-Tooth disease type 2D.